<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7270404\results\search\disease\results.xml">
  <result pre="Kingdom *Correspondence: Jean-Michel Sallenave jean-michel.sallenave@inserm.fr This article was submitted to" exact="Viral" post="Immunology, a section of the journal Frontiers in Immunology"/>
  <result pre="comply with these terms. Abstract COVID-19 is caused by the" exact="Severe" post="Acute Respiratory Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus"/>
  <result pre="with these terms. Abstract COVID-19 is caused by the Severe" exact="Acute" post="Respiratory Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus with"/>
  <result pre="these terms. Abstract COVID-19 is caused by the Severe Acute" exact="Respiratory" post="Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus with a"/>
  <result pre="terms. Abstract COVID-19 is caused by the Severe Acute Respiratory" exact="Syndrome" post="(SARS) coronavirus (Cov)-2, an enveloped virus with a positive-polarity,"/>
  <result pre="(Influenza H1N1 and SARS-CoV) and the epidemics of Middle east" exact="respiratory" post="syndrome (MERS)-CoV, CoVs target bronchial and alveolar epithelial cells."/>
  <result pre="H1N1 and SARS-CoV) and the epidemics of Middle east respiratory" exact="syndrome" post="(MERS)-CoV, CoVs target bronchial and alveolar epithelial cells. Virus"/>
  <result pre="Middle east respiratory syndrome (MERS)-CoV, CoVs target bronchial and alveolar" exact="epithelial" post="cells. Virus protein ligands (e.g., haemagglutinin or trimeric spike"/>
  <result pre="(ACE2). Host proteases, e.g., cathepsins, furin, or members of the" exact="type II" post="transmembrane serine proteases (TTSP) family, such as Transmembrane protease"/>
  <result pre="upregulate anti-viral and pro-inflammatory mediators [interleukin (IL)-6 and IL-8 and" exact="type I" post="and type III Interferons among others], through the activation"/>
  <result pre="pro-inflammatory mediators [interleukin (IL)-6 and IL-8 and type I and" exact="type III" post="Interferons among others], through the activation of Nuclear Factor"/>
  <result pre="cellular entry and innate immune responses) are uncontrolled, a deleterious" exact="systemic" post="response is sometimes encountered in infected patients, leading to"/>
  <result pre="T-cell function. We aim to describe how the lung and" exact="systemic" post="host innate immune responses affect survival either positively, through"/>
  <result pre="innate immune responses affect survival either positively, through downregulating initial" exact="viral" post="load, or negatively, by triggering uncontrolled inflammation. An emphasis"/>
  <result pre="positively, through downregulating initial viral load, or negatively, by triggering" exact="uncontrolled" post="inflammation. An emphasis will be put on host cellular"/>
  <result pre="fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction COVID-19 is a" exact="respiratory" post="disease whose aetiologic agent is a novel beta coronavirus"/>
  <result pre="table-count: equation-count: ref-count: page-count: word-count: Introduction COVID-19 is a respiratory" exact="disease" post="whose aetiologic agent is a novel beta coronavirus (CoV)"/>
  <result pre="whose aetiologic agent is a novel beta coronavirus (CoV) called" exact="Severe" post="Acute Respiratory Syndrome (SARS)-CoV-2/2019-nCov. The initial outbreak of the"/>
  <result pre="aetiologic agent is a novel beta coronavirus (CoV) called Severe" exact="Acute" post="Respiratory Syndrome (SARS)-CoV-2/2019-nCov. The initial outbreak of the pandemic"/>
  <result pre="agent is a novel beta coronavirus (CoV) called Severe Acute" exact="Respiratory" post="Syndrome (SARS)-CoV-2/2019-nCov. The initial outbreak of the pandemic began"/>
  <result pre="is a novel beta coronavirus (CoV) called Severe Acute Respiratory" exact="Syndrome" post="(SARS)-CoV-2/2019-nCov. The initial outbreak of the pandemic began in"/>
  <result pre="SARS-CoV-2 outbreak, two related highly pathogenic CoVs viruses, Middle east" exact="respiratory" post="syndrome (MERS)-CoV (1) and SARS-CoV (2), provoked catastrophic epidemics"/>
  <result pre="outbreak, two related highly pathogenic CoVs viruses, Middle east respiratory" exact="syndrome" post="(MERS)-CoV (1) and SARS-CoV (2), provoked catastrophic epidemics and"/>
  <result pre="vaccines have currently been approved to prevent or treat these" exact="viral" post="episodes. The first anatomical/histological reports from the lungs of"/>
  <result pre="anatomical/histological reports from the lungs of severely SARS-CoV-2-affected patients experiencing" exact="acute" post="respiratory disease syndrome (ARDS) revealed excessive inflammatory activation and"/>
  <result pre="reports from the lungs of severely SARS-CoV-2-affected patients experiencing acute" exact="respiratory" post="disease syndrome (ARDS) revealed excessive inflammatory activation and destruction"/>
  <result pre="from the lungs of severely SARS-CoV-2-affected patients experiencing acute respiratory" exact="disease" post="syndrome (ARDS) revealed excessive inflammatory activation and destruction of"/>
  <result pre="the lungs of severely SARS-CoV-2-affected patients experiencing acute respiratory disease" exact="syndrome" post="(ARDS) revealed excessive inflammatory activation and destruction of the"/>
  <result pre="2003 (3, 4). Indeed, in the latter pandemic, lung alveolar" exact="epithelial" post="cells were identified as the most likely site of"/>
  <result pre="is no doubt that the latter are involved in modulating" exact="disease" post="onset and progression. For example, early studies report that,"/>
  <result pre="studies report that, similarly with what was observed with SARS-CoV," exact="lymphopenia" post="[sometimes equivalent or more severe than that observed in"/>
  <result pre="[sometimes equivalent or more severe than that observed in human" exact="immunodeficiency" post="virus (HIV) infection] is often observed in severely affected"/>
  <result pre="aberrant non-effective innate immune host responses seem associated with severe" exact="lung disease" post="during SARS (6â€&quot;12). The following sections will give an"/>
  <result pre="non-effective innate immune host responses seem associated with severe lung" exact="disease" post="during SARS (6â€&quot;12). The following sections will give an"/>
  <result pre="overview of the molecular and cellular mechanisms underpinning SARS-CoV virus" exact="infections" post="and how lung and systemic host innate immune responses"/>
  <result pre="cellular mechanisms underpinning SARS-CoV virus infections and how lung and" exact="systemic" post="host innate immune responses affect survival either positively, through"/>
  <result pre="immune responses affect survival either positively, through downregulating the initial" exact="viral" post="load, or negatively, by triggering uncontrolled inflammation. A particular"/>
  <result pre="through downregulating the initial viral load, or negatively, by triggering" exact="uncontrolled" post="inflammation. A particular emphasis will be put on the"/>
  <result pre="(N) (13). Figure 1 Schematic representation of airway and lung" exact="infection" post="by SARS-CoV-2 at early time points (A) and during"/>
  <result pre="is covered by mucus (M) involved in the mucociliary clearance." exact="Distal" post="to the lung, the alveoli include alveolar type I"/>
  <result pre="mucociliary clearance. Distal to the lung, the alveoli include alveolar" exact="type I" post="(ATI) and type II (ATII) cells coated with surfactant"/>
  <result pre="the lung, the alveoli include alveolar type I (ATI) and" exact="type II" post="(ATII) cells coated with surfactant (S). The airways are"/>
  <result pre="enzyme 2 (ACE2), SARS-CoV-2 can enter and replicate into airway" exact="epithelial" post="cells and AM. Also, interaction of the SARS-CoV-2 with"/>
  <result pre="and tissue damage. The entry of CoV viruses into host" exact="epithelial" post="cells is mediated by the interaction between the viral"/>
  <result pre="host epithelial cells is mediated by the interaction between the" exact="viral" post="envelope S protein homotrimers and the cell surface receptors."/>
  <result pre="the S2 C-terminal domain is involved in cell fusion and" exact="viral" post="entry (14â€&quot;16). This mechanism of action is very similar"/>
  <result pre="in virus activation, including neutrophil elastase (21), proteases of the" exact="type II" post="transmembrane serine proteases (TTSP) family [HAT, Transmembrane protease, serine"/>
  <result pre="it is very likely that SARS-CoV and SARS-CoV-2 target mainly" exact="respiratory" post="epithelial cells with similar mechanisms. Indeed, as indicated above,"/>
  <result pre="is very likely that SARS-CoV and SARS-CoV-2 target mainly respiratory" exact="epithelial" post="cells with similar mechanisms. Indeed, as indicated above, initial"/>
  <result pre="Indeed, â€œseasonalâ€� low pathogenic CoVs (e.g., CoV-229E, CoV-OC43) infect mostly" exact="upper" post="airways, whereas pathogenic CoVs (SARS-CoV/SARS-CoV-2 and MERS) have a"/>
  <result pre="a tropism for the distal lung and can cause severe" exact="pneumonia" post="and ARDS (32), as currently demonstrated again in the"/>
  <result pre="coronaviruses do not use ACE2 as a receptor. In vitro," exact="primary" post="nasal and tracheobronchial epithelial cells as well as the"/>
  <result pre="ACE2 as a receptor. In vitro, primary nasal and tracheobronchial" exact="epithelial" post="cells as well as the Calu-3 bronchial cell line"/>
  <result pre="express ACE2 (the latter not colocalizing with cilia), and their" exact="infection" post="with SARS-CoV was shown to be highly cytotoxic (33,"/>
  <result pre="cytotoxic (33, 34). In the distal lung, as hinted above," exact="primary" post="alveolar type II epithelial (ATII) cells are also permissive"/>
  <result pre="34). In the distal lung, as hinted above, primary alveolar" exact="type II" post="epithelial (ATII) cells are also permissive to SARS-CoV infection"/>
  <result pre="the distal lung, as hinted above, primary alveolar type II" exact="epithelial" post="(ATII) cells are also permissive to SARS-CoV infection (35,"/>
  <result pre="type II epithelial (ATII) cells are also permissive to SARS-CoV" exact="infection" post="(35, 36). SARS-CoV-2 has also been shown to infect"/>
  <result pre="(35, 36). SARS-CoV-2 has also been shown to infect various" exact="respiratory" post="epithelial cell lines including A549 (alveolar origin), BEAS2-B (bronchial"/>
  <result pre="36). SARS-CoV-2 has also been shown to infect various respiratory" exact="epithelial" post="cell lines including A549 (alveolar origin), BEAS2-B (bronchial origin),"/>
  <result pre="(alveolar origin), BEAS2-B (bronchial origin), Calu-3 cells, as well as" exact="primary" post="human bronchial epithelial cells (24). Besides the lung, ACE2"/>
  <result pre="(bronchial origin), Calu-3 cells, as well as primary human bronchial" exact="epithelial" post="cells (24). Besides the lung, ACE2 is also highly"/>
  <result pre="infect enterocytes as well as intestinal organoids and induces a" exact="viral" post="response characterized by the expression of mediators related to"/>
  <result pre="viral response characterized by the expression of mediators related to" exact="type I" post="and III IFN (39). Even if SARS-CoV2 is thought"/>
  <result pre="Even if SARS-CoV2 is thought to originate from bats, the" exact="intermediate" post="host between bats and humans is still unknown. SARS-CoV"/>
  <result pre="a number of viruses, it is no surprise that, upon" exact="virus infection," post="murine knock-out (KO) for some of these molecules has"/>
  <result pre="shown some protection. For example, TMPRSS2-KO mice were protected from" exact="pulmonary" post="disease and death following H1N1 and H7N9 Influenza infection,"/>
  <result pre="some protection. For example, TMPRSS2-KO mice were protected from pulmonary" exact="disease" post="and death following H1N1 and H7N9 Influenza infection, but"/>
  <result pre="(44â€&quot;47). Similarly, TMPRSS2 KO mice showed reduced body weight and" exact="viral" post="loads compared to WT mice in animals infected with"/>
  <result pre="the human DPP4 in mice promoted MERS-CoV infection, causing lethal" exact="disease" post="(49), and that TMPRSS2 was instrumental in that context"/>
  <result pre="Signaling Pathways (SEE FIGURE 1A) Epithelial Cells The control of" exact="viral infection" post="requires an optimal and innate coordinated host antiviral immunity."/>
  <result pre="Pathways (SEE FIGURE 1A) Epithelial Cells The control of viral" exact="infection" post="requires an optimal and innate coordinated host antiviral immunity."/>
  <result pre="which recognize pathogen-associated molecular patterns (PAMPs). Although for many viruses," exact="viral" post="RNA is a PAMP classically detected by different sensors,"/>
  <result pre="and TLR8 [which sense single stranded (ss)RNA], RIG-I (which senses" exact="short" post="dsRNA and ssRNA specific motifs), and MDA-5 (which senses"/>
  <result pre="are still elusive. In addition, although, as mentioned above, distal" exact="peripheral" post="lung alveolar epithelial cells seem to harbor SARS-CoV infection"/>
  <result pre="In addition, although, as mentioned above, distal peripheral lung alveolar" exact="epithelial" post="cells seem to harbor SARS-CoV infection in vivo, and"/>
  <result pre="distal peripheral lung alveolar epithelial cells seem to harbor SARS-CoV" exact="infection" post="in vivo, and although respiratory epithelial cells are known"/>
  <result pre="cells seem to harbor SARS-CoV infection in vivo, and although" exact="respiratory" post="epithelial cells are known to express TLR3, TLR7, and"/>
  <result pre="seem to harbor SARS-CoV infection in vivo, and although respiratory" exact="epithelial" post="cells are known to express TLR3, TLR7, and TLR8"/>
  <result pre="virus in vitro (except for intestinal Caco-2 and HEK293 kidney" exact="epithelial" post="cells) (54). In that respect, although the specific PRR"/>
  <result pre="(ALI)] is the model of choice: in that set-up, SARS-CoV" exact="infection" post="triggered an inflammatory response characterized by increased production of"/>
  <result pre="the kinetics of this response was extremely slow, and importantly," exact="type I" post="IFN, an important mediator of anti-viral responses, was undetected."/>
  <result pre="CCL2, an important monocytic chemokine (57). In addition to lung" exact="epithelial" post="cells cultured at ALI, precision-cut lung slices could also"/>
  <result pre="tool to study SARS-CoV2-cells interactions (58), as demonstrated in Influenza" exact="infections" post="with human (59) or animal-derived material (60). As mentioned"/>
  <result pre="is able to activate mucin gene expression in NCI-H292 lung" exact="epithelial" post="cells (61). Relatedly, we have shown both in vitro"/>
  <result pre="cells (61). Relatedly, we have shown both in vitro in" exact="epithelial" post="cells and in a murine model that Influenza H3N2"/>
  <result pre="production (64). Importantly, after having established a foothold in the" exact="epithelial" post="compartment, SARS-CoV can disrupt the epithelial polarity, thereby getting"/>
  <result pre="a foothold in the epithelial compartment, SARS-CoV can disrupt the" exact="epithelial" post="polarity, thereby getting access to the parenchyma tissue: for"/>
  <result pre="Associated With Lin Seven 1), a junction protein involved in" exact="epithelial" post="polarity, and modifies its cellular distribution at the surface"/>
  <result pre="its cellular distribution at the surface of HEK-293 cells (65)." exact="Myeloid" post="Cells and Myeloid-Epithelial Cells Interaction Myeloid cells, e.g., alveolar"/>
  <result pre="of HEK-293 cells (65). Myeloid Cells and Myeloid-Epithelial Cells Interaction" exact="Myeloid" post="cells, e.g., alveolar and interstitial macrophages or dendritic cells"/>
  <result pre="could, through TLR2, trigger NF-ÎºB activation and inflammatory responses in" exact="peripheral" post="blood mononuclear cells (PBMC) (69). Also, in common with"/>
  <result pre="peripheral blood mononuclear cells (PBMC) (69). Also, in common with" exact="epithelial" post="cells, it was shown that PBMCs and DCs infected"/>
  <result pre="expression, the SARS-Cov-2 receptor, which may explain in part patients'" exact="susceptibility to" post="infection. Genes associated with TLR pathways also represent good"/>
  <result pre="TLR pathways also represent good candidates, as demonstrated in other" exact="respiratory" post="viral infection (e.g., influenza) where TLR3 variants (76) were"/>
  <result pre="pathways also represent good candidates, as demonstrated in other respiratory" exact="viral infection" post="(e.g., influenza) where TLR3 variants (76) were shown to"/>
  <result pre="also represent good candidates, as demonstrated in other respiratory viral" exact="infection" post="(e.g., influenza) where TLR3 variants (76) were shown to"/>
  <result pre="responses, including â€œcytokine stormâ€� events, have been associated with severe" exact="lung disease" post="and the development of ARDS during SARS and the"/>
  <result pre="including â€œcytokine stormâ€� events, have been associated with severe lung" exact="disease" post="and the development of ARDS during SARS and the"/>
  <result pre="prolonged (albeit delayed, as demonstrated also in vitro, see above)" exact="type I" post="IFN signaling was instrumental in triggering over-exuberant innate inflammatory"/>
  <result pre="shown that excessive complement activation was partly responsible for exacerbated" exact="lung inflammation" post="(84). Lastly, â€œcytokines stormâ€� may also results from SOCS"/>
  <result pre="upon Influenza infection, SOCS1 and SOCS3 were shown to reduce" exact="type I" post="IFN antiviral responses in human bronchial epithelial cells (86)."/>
  <result pre="to reduce type I IFN antiviral responses in human bronchial" exact="epithelial" post="cells (86). Also, SOCS4-deficient mice exhibited heightened sensitivity to"/>
  <result pre="cells (86). Also, SOCS4-deficient mice exhibited heightened sensitivity to Influenza" exact="infection" post="(87). Studies about SOCS involvement during coronavirus infections are"/>
  <result pre="to Influenza infection (87). Studies about SOCS involvement during coronavirus" exact="infections" post="are currently lacking and should therefore bring new interesting"/>
  <result pre="in that category are trials testing molecules aiming to block" exact="viral" post="entry at the cellular surface by targeting ACE-inhibitors (32"/>
  <result pre="anti-inflammatory drugs could/should be prescribed during that stage of the" exact="disease" post="(8). In that context, â€œclassicalâ€� anti-inflammatory drugs are indeed"/>
  <result pre="anti-inflammatory molecule, and it has notably been used in inflammatory" exact="rheumatic" post="diseases (89). Despite a relative safe profile, having been"/>
  <result pre="a blueprint for the design of vaccines and inhibitors of" exact="viral" post="entry (28). In this context, promising results show that"/>
  <result pre="demonstrated that Bacille Calmette-Guerin (BCG) can heterologously protect against virus" exact="infections" post="[e.g., yellow fever virus (94), probably by tapping on"/>
  <result pre="Bacille Calmette-Guerin (BCG) can heterologously protect against virus infections [e.g.," exact="yellow fever" post="virus (94), probably by tapping on trained immunity mechanisms"/>
  <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
  <result pre="human coronavirus threat. Viruses. (2018) 10:93. 10.20944/preprints201711.0198.v229495250 2.PeirisJSYuenKYOsterhausADStohrK. The severe" exact="acute" post="respiratory syndrome. N Engl J Med. (2003) 349:2431â€&quot;41. 10.1056/NEJMra03249814681510"/>
  <result pre="coronavirus threat. Viruses. (2018) 10:93. 10.20944/preprints201711.0198.v229495250 2.PeirisJSYuenKYOsterhausADStohrK. The severe acute" exact="respiratory" post="syndrome. N Engl J Med. (2003) 349:2431â€&quot;41. 10.1056/NEJMra03249814681510 3.NichollsJMPoonLLLeeKCNgWFLaiSTLeungCYet"/>
  <result pre="(2003) 349:2431â€&quot;41. 10.1056/NEJMra03249814681510 3.NichollsJMPoonLLLeeKCNgWFLaiSTLeungCYet al.. Lung pathology of fatal severe" exact="acute" post="respiratory syndrome. Lancet. (2003) 361:1773â€&quot;8. 10.1016/S0140-6736(03)13413-712781536 4.GuJGongEZhangBZhengJGaoZZhongYet al.. Multiple"/>
  <result pre="349:2431â€&quot;41. 10.1056/NEJMra03249814681510 3.NichollsJMPoonLLLeeKCNgWFLaiSTLeungCYet al.. Lung pathology of fatal severe acute" exact="respiratory" post="syndrome. Lancet. (2003) 361:1773â€&quot;8. 10.1016/S0140-6736(03)13413-712781536 4.GuJGongEZhangBZhengJGaoZZhongYet al.. Multiple organ"/>
  <result pre="severe acute respiratory syndrome. Lancet. (2003) 361:1773â€&quot;8. 10.1016/S0140-6736(03)13413-712781536 4.GuJGongEZhangBZhengJGaoZZhongYet al.." exact="Multiple" post="organ infection and the pathogenesis of SARS. J Exp"/>
  <result pre="respiratory syndrome. Lancet. (2003) 361:1773â€&quot;8. 10.1016/S0140-6736(03)13413-712781536 4.GuJGongEZhangBZhengJGaoZZhongYet al.. Multiple organ" exact="infection" post="and the pathogenesis of SARS. J Exp Med. (2005)"/>
  <result pre="al.. Clinical and immunologic features in severe and moderate Coronavirus" exact="Disease" post="2019. J Clin Invest. (2020) 130:2620â€&quot;9. 10.1172/JCI13724432217835 7.Giamarellos-BourboulisEJNeteaMGRovinaNAkinosoglouKAntoniadouAAntonakosNet al.."/>
  <result pre="Disease 2019. J Clin Invest. (2020) 130:2620â€&quot;9. 10.1172/JCI13724432217835 7.Giamarellos-BourboulisEJNeteaMGRovinaNAkinosoglouKAntoniadouAAntonakosNet al.." exact="Complex" post="immune dysregulation in COVID-19 patients with severe respiratory failure."/>
  <result pre="7.Giamarellos-BourboulisEJNeteaMGRovinaNAkinosoglouKAntoniadouAAntonakosNet al.. Complex immune dysregulation in COVID-19 patients with severe" exact="respiratory" post="failure. Cell Host Microbe. (2020) 10.1016/j.chom.2020.04.009. [Epub ahead of"/>
  <result pre="Med. (2020) 26:453â€&quot;5. 10.1038/s41591-020-0819-232284614 11.WuCChenXCaiYXiaJZhouXXuSet al.. Risk factors associated with" exact="acute" post="respiratory distress syndrome and death in patients with Coronavirus"/>
  <result pre="(2020) 26:453â€&quot;5. 10.1038/s41591-020-0819-232284614 11.WuCChenXCaiYXiaJZhouXXuSet al.. Risk factors associated with acute" exact="respiratory" post="distress syndrome and death in patients with Coronavirus Disease"/>
  <result pre="10.1038/s41591-020-0819-232284614 11.WuCChenXCaiYXiaJZhouXXuSet al.. Risk factors associated with acute respiratory distress" exact="syndrome" post="and death in patients with Coronavirus Disease 2019 pneumonia"/>
  <result pre="acute respiratory distress syndrome and death in patients with Coronavirus" exact="Disease" post="2019 pneumonia in Wuhan, China. JAMA Intern Med. (2020)."/>
  <result pre="distress syndrome and death in patients with Coronavirus Disease 2019" exact="pneumonia" post="in Wuhan, China. JAMA Intern Med. (2020). 10.1001/jamainternmed.2020.0994. [Epub"/>
  <result pre="Intern Med. (2020). 10.1001/jamainternmed.2020.0994. [Epub ahead of print].32167524 12.ZhengHYZhangMYangCXZhangNWangXCYangXPet al.." exact="Elevated" post="exhaustion levels and reduced functional diversity of T cells"/>
  <result pre="exhaustion levels and reduced functional diversity of T cells in" exact="peripheral" post="blood may predict severe progression in COVID-19 patients. Cell"/>
  <result pre="coronavirus tropism and pathogenesis. Virus Res. (2015) 202:120â€&quot;34. 10.1016/j.virusres.2014.11.02125445340 15.TortoriciMAVeeslerD." exact="Structural" post="insights into coronavirus entry. Adv Virus Res. (2019) 105:93â€&quot;116."/>
  <result pre="of the same clade. Antiviral Res. (2020) 176:104742. 10.1016/j.antiviral.2020.10474232057769 17.BuggeTHAntalisTMWuQ." exact="Type II" post="transmembrane serine proteases. J Biol Chem. (2009) 284:23177â€&quot;81. 10.1074/jbc.R109.02100619487698"/>
  <result pre="transmembrane serine proteases. J Biol Chem. (2009) 284:23177â€&quot;81. 10.1074/jbc.R109.02100619487698 18.ChoiSYBertramSGlowackaIParkYWPohlmannS." exact="Type II" post="transmembrane serine proteases in cancer and viral infections. Trends"/>
  <result pre="(2009) 284:23177â€&quot;81. 10.1074/jbc.R109.02100619487698 18.ChoiSYBertramSGlowackaIParkYWPohlmannS. Type II transmembrane serine proteases in" exact="cancer" post="and viral infections. Trends Mol Med. (2009) 15:303â€&quot;12. 10.1016/j.molmed.2009.05.00319581128"/>
  <result pre="10.1074/jbc.R109.02100619487698 18.ChoiSYBertramSGlowackaIParkYWPohlmannS. Type II transmembrane serine proteases in cancer and" exact="viral" post="infections. Trends Mol Med. (2009) 15:303â€&quot;12. 10.1016/j.molmed.2009.05.00319581128 19.Bottcher-FriebertshauserEKlenkHDGartenW. Activation"/>
  <result pre="Cell Biol. (2015) 94:375â€&quot;83. 10.1016/j.ejcb.2015.05.01326095298 21.MatsuyamaSUjikeMMorikawaSTashiroMTaguchiF. Protease-mediated enhancement of severe" exact="acute" post="respiratory syndrome coronavirus infection. Proc Natl Acad Sci USA."/>
  <result pre="Biol. (2015) 94:375â€&quot;83. 10.1016/j.ejcb.2015.05.01326095298 21.MatsuyamaSUjikeMMorikawaSTashiroMTaguchiF. Protease-mediated enhancement of severe acute" exact="respiratory" post="syndrome coronavirus infection. Proc Natl Acad Sci USA. (2005)"/>
  <result pre="(2015) 94:375â€&quot;83. 10.1016/j.ejcb.2015.05.01326095298 21.MatsuyamaSUjikeMMorikawaSTashiroMTaguchiF. Protease-mediated enhancement of severe acute respiratory" exact="syndrome" post="coronavirus infection. Proc Natl Acad Sci USA. (2005) 102:12543â€&quot;7."/>
  <result pre="80:9896â€&quot;8. 10.1128/JVI.01118-0616973594 23.BertramSGlowackaIMullerMALavenderHGnirssKNehlmeierIet al.. Cleavage and activation of the severe" exact="acute" post="respiratory syndrome coronavirus spike protein by human airway trypsin-like"/>
  <result pre="10.1128/JVI.01118-0616973594 23.BertramSGlowackaIMullerMALavenderHGnirssKNehlmeierIet al.. Cleavage and activation of the severe acute" exact="respiratory" post="syndrome coronavirus spike protein by human airway trypsin-like protease."/>
  <result pre="23.BertramSGlowackaIMullerMALavenderHGnirssKNehlmeierIet al.. Cleavage and activation of the severe acute respiratory" exact="syndrome" post="coronavirus spike protein by human airway trypsin-like protease. J"/>
  <result pre="SARS coronavirus-induced lung injury. Nat Med. (2005) 11:875â€&quot;9. 10.1038/nm126716007097 30.YanRZhangYLiYXiaLGuoYZhouQ." exact="Structural" post="basis for the recognition of the SARS-CoV-2 by full-length"/>
  <result pre="cytokine storm and immunopathology. Semin Immunopathol. (2017) 39:529â€&quot;39. 10.1007/s00281-017-0629-x28466096 33.SimsACBaricRSYountBBurkettSECollinsPLPicklesRJ." exact="Severe" post="acute respiratory syndrome coronavirus infection of human ciliated airway"/>
  <result pre="storm and immunopathology. Semin Immunopathol. (2017) 39:529â€&quot;39. 10.1007/s00281-017-0629-x28466096 33.SimsACBaricRSYountBBurkettSECollinsPLPicklesRJ. Severe" exact="acute" post="respiratory syndrome coronavirus infection of human ciliated airway epithelia:"/>
  <result pre="and immunopathology. Semin Immunopathol. (2017) 39:529â€&quot;39. 10.1007/s00281-017-0629-x28466096 33.SimsACBaricRSYountBBurkettSECollinsPLPicklesRJ. Severe acute" exact="respiratory" post="syndrome coronavirus infection of human ciliated airway epithelia: role"/>
  <result pre="immunopathology. Semin Immunopathol. (2017) 39:529â€&quot;39. 10.1007/s00281-017-0629-x28466096 33.SimsACBaricRSYountBBurkettSECollinsPLPicklesRJ. Severe acute respiratory" exact="syndrome" post="coronavirus infection of human ciliated airway epithelia: role of"/>
  <result pre="Immunopathol. (2017) 39:529â€&quot;39. 10.1007/s00281-017-0629-x28466096 33.SimsACBaricRSYountBBurkettSECollinsPLPicklesRJ. Severe acute respiratory syndrome coronavirus" exact="infection" post="of human ciliated airway epithelia: role of ciliated cells"/>
  <result pre="of human ciliated airway epithelia: role of ciliated cells in" exact="viral" post="spread in the conducting airways of the lungs. J"/>
  <result pre="Virus Res. (2008) 133:33â€&quot;44. 10.1016/j.virusres.2007.03.01317451829 35.MosselECWangJJeffersSEdeenKEWangSCosgroveGPet al.. SARS-CoV replicates in" exact="primary" post="human alveolar type II cell cultures but not in"/>
  <result pre="133:33â€&quot;44. 10.1016/j.virusres.2007.03.01317451829 35.MosselECWangJJeffersSEdeenKEWangSCosgroveGPet al.. SARS-CoV replicates in primary human alveolar" exact="type II" post="cell cultures but not in type I-like cells. Virology."/>
  <result pre="372:127â€&quot;35. 10.1016/j.virol.2007.09.04518022664 36.QianZTravantyEAOkoLEdeenKBerglundAWangJet al.. Innate immune response of human alveolar" exact="type II" post="cells infected with severe acute respiratory syndrome-coronavirus. Am J"/>
  <result pre="response of human alveolar type II cells infected with severe" exact="acute" post="respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. (2013)"/>
  <result pre="of human alveolar type II cells infected with severe acute" exact="respiratory" post="syndrome-coronavirus. Am J Respir Cell Mol Biol. (2013) 48:742â€&quot;8."/>
  <result pre="China. Science. (2003) 302:276â€&quot;8. 10.1126/science.108713912958366 41.MartinaBEHaagmansBLKuikenTFouchierRARimmelzwaanGFVan AmerongenGet al.. Virology: SARS" exact="virus infection" post="of cats and ferrets. Nature. (2003) 425:915. 10.1038/425915a14586458 42.ChenWYanMYangLDingBHeBWangYet"/>
  <result pre="Science. (2003) 302:276â€&quot;8. 10.1126/science.108713912958366 41.MartinaBEHaagmansBLKuikenTFouchierRARimmelzwaanGFVan AmerongenGet al.. Virology: SARS virus" exact="infection" post="of cats and ferrets. Nature. (2003) 425:915. 10.1038/425915a14586458 42.ChenWYanMYangLDingBHeBWangYet"/>
  <result pre="(2019) 93:e01815-18. 10.1128/JVI.01815-1830626688 49.LiKWohlford-LenaneCLChannappanavarRParkJEEarnestJTBairTBet al.. Mouse-adapted MERS coronavirus causes lethal" exact="lung disease" post="in human DPP4 knockin mice. Proc Natl Acad Sci"/>
  <result pre="93:e01815-18. 10.1128/JVI.01815-1830626688 49.LiKWohlford-LenaneCLChannappanavarRParkJEEarnestJTBairTBet al.. Mouse-adapted MERS coronavirus causes lethal lung" exact="disease" post="in human DPP4 knockin mice. Proc Natl Acad Sci"/>
  <result pre="of toll-like receptor 3 in the immune response of lung" exact="epithelial" post="cells to double-stranded RNA and influenza A virus. J"/>
  <result pre="(2005) 280:5571â€&quot;80. 10.1074/jbc.M41059220015579900 52.IoannidisIYeFMcNallyBWilletteMFlanoE. Toll-like receptor expression and induction of" exact="type I" post="and type III interferons in primary airway epithelial cells."/>
  <result pre="52.IoannidisIYeFMcNallyBWilletteMFlanoE. Toll-like receptor expression and induction of type I and" exact="type III" post="interferons in primary airway epithelial cells. J Virol. (2013)"/>
  <result pre="and induction of type I and type III interferons in" exact="primary" post="airway epithelial cells. J Virol. (2013) 87:3261â€&quot;70. 10.1128/JVI.01956-1223302870 53.WhitsettJAAlenghatT."/>
  <result pre="of type I and type III interferons in primary airway" exact="epithelial" post="cells. J Virol. (2013) 87:3261â€&quot;70. 10.1128/JVI.01956-1223302870 53.WhitsettJAAlenghatT. Respiratory epithelial"/>
  <result pre="primary airway epithelial cells. J Virol. (2013) 87:3261â€&quot;70. 10.1128/JVI.01956-1223302870 53.WhitsettJAAlenghatT." exact="Respiratory" post="epithelial cells orchestrate pulmonary innate immunity. Nat Immunol. (2015)"/>
  <result pre="airway epithelial cells. J Virol. (2013) 87:3261â€&quot;70. 10.1128/JVI.01956-1223302870 53.WhitsettJAAlenghatT. Respiratory" exact="epithelial" post="cells orchestrate pulmonary innate immunity. Nat Immunol. (2015) 16:27â€&quot;35."/>
  <result pre="J Virol. (2013) 87:3261â€&quot;70. 10.1128/JVI.01956-1223302870 53.WhitsettJAAlenghatT. Respiratory epithelial cells orchestrate" exact="pulmonary" post="innate immunity. Nat Immunol. (2015) 16:27â€&quot;35. 10.1038/ni.304525521682 54.FriemanMHeiseMBaricR. SARS"/>
  <result pre="Res. (2008) 133:101â€&quot;12. 10.1016/j.virusres.2007.03.01517451827 55.WangYLiuL. The membrane protein of severe" exact="acute" post="respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated"/>
  <result pre="(2008) 133:101â€&quot;12. 10.1016/j.virusres.2007.03.01517451827 55.WangYLiuL. The membrane protein of severe acute" exact="respiratory" post="syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular"/>
  <result pre="133:101â€&quot;12. 10.1016/j.virusres.2007.03.01517451827 55.WangYLiuL. The membrane protein of severe acute respiratory" exact="syndrome" post="coronavirus functions as a novel cytosolic pathogen-associated molecular pattern"/>
  <result pre="of severe acute respiratory syndrome coronavirus functions as a novel" exact="cytosolic" post="pathogen-associated molecular pattern to promote beta interferon induction via"/>
  <result pre="via a toll-like-receptor-related TRAF3-independent mechanism. MBio. (2016) 7:e01872â€&quot;15. 10.1128/mBio.01872-1526861016 56.YoshikawaTHillTLiKPetersCJTsengCT." exact="Severe" post="acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate"/>
  <result pre="a toll-like-receptor-related TRAF3-independent mechanism. MBio. (2016) 7:e01872â€&quot;15. 10.1128/mBio.01872-1526861016 56.YoshikawaTHillTLiKPetersCJTsengCT. Severe" exact="acute" post="respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS"/>
  <result pre="toll-like-receptor-related TRAF3-independent mechanism. MBio. (2016) 7:e01872â€&quot;15. 10.1128/mBio.01872-1526861016 56.YoshikawaTHillTLiKPetersCJTsengCT. Severe acute" exact="respiratory" post="syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis"/>
  <result pre="TRAF3-independent mechanism. MBio. (2016) 7:e01872â€&quot;15. 10.1128/mBio.01872-1526861016 56.YoshikawaTHillTLiKPetersCJTsengCT. Severe acute respiratory" exact="syndrome" post="(SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by"/>
  <result pre="7:e01872â€&quot;15. 10.1128/mBio.01872-1526861016 56.YoshikawaTHillTLiKPetersCJTsengCT. Severe acute respiratory syndrome (SARS) coronavirus-induced lung" exact="epithelial" post="cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of"/>
  <result pre="of the chemokine (C-C motif) ligand 2 via a severe" exact="acute" post="respiratory syndrome coronavirus spike-ACE2 signaling pathway. J Virol. (2010)"/>
  <result pre="the chemokine (C-C motif) ligand 2 via a severe acute" exact="respiratory" post="syndrome coronavirus spike-ACE2 signaling pathway. J Virol. (2010) 84:7703â€&quot;12."/>
  <result pre="chemokine (C-C motif) ligand 2 via a severe acute respiratory" exact="syndrome" post="coronavirus spike-ACE2 signaling pathway. J Virol. (2010) 84:7703â€&quot;12. 10.1128/JVI.02560-0920484496"/>
  <result pre="58.AlsafadiHNUhlFEPinedaRHBaileyKERojasMWagnerDEet al.. Applications and approaches for 3D precision-cut lung slices:" exact="disease" post="modeling and drug discovery. Am J Respir Cell Mol"/>
  <result pre="59.WuWBoothJLDugganESWuSPatelKBCoggeshallKMet al.. Innate immune response to H3N2 and H1N1 influenza" exact="virus infection" post="in a human lung organ culture model. Virology. (2010)"/>
  <result pre="al.. Innate immune response to H3N2 and H1N1 influenza virus" exact="infection" post="in a human lung organ culture model. Virology. (2010)"/>
  <result pre="10.1016/j.virol.2009.10.01619913271 60.Delgado-OrtegaMMeloSPunyadarsaniyaDRameCOlivierMSoubieuxDet al.. Innate immune response to a H3N2 subtype" exact="swine influenza" post="virus in newborn porcine trachea cells, alveolar macrophages, and"/>
  <result pre="Human airway trypsin-like protease increases mucin gene expression in airway" exact="epithelial" post="cells. Am J Respir Cell Mol Biol. (2004) 30:470â€&quot;8."/>
  <result pre="mitochondrial antiviral immunity by blocking the autophagic flux in lung" exact="epithelial" post="cells. ACS Nano. (2018) 12:1188â€&quot;202. 10.1021/acsnano.7b0693429357226 65.TeohKTSiuYLChanWLSchluterMALiuCJPeirisJSet al.. The"/>
  <result pre="protein interacts with PALS1 and alters tight junction formation and" exact="epithelial" post="morphogenesis. Mol Biol Cell. (2010) 21:3838â€&quot;52. 10.1091/mbc.e10-04-033820861307 66.DuanMHibbsMLChenW. The"/>
  <result pre="(2010) 21:3838â€&quot;52. 10.1091/mbc.e10-04-033820861307 66.DuanMHibbsMLChenW. The contributions of lung macrophage and" exact="monocyte" post="heterogeneity to influenza pathogenesis. Immunol Cell Biol. (2017) 95:225â€&quot;35."/>
  <result pre="Biol. (2017) 95:225â€&quot;35. 10.1038/icb.2016.9727670791 67.CheungCYPoonLLNgIHLukWSiaSFWuMHet al.. Cytokine responses in severe" exact="acute" post="respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to"/>
  <result pre="(2017) 95:225â€&quot;35. 10.1038/icb.2016.9727670791 67.CheungCYPoonLLNgIHLukWSiaSFWuMHet al.. Cytokine responses in severe acute" exact="respiratory" post="syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis."/>
  <result pre="95:225â€&quot;35. 10.1038/icb.2016.9727670791 67.CheungCYPoonLLNgIHLukWSiaSFWuMHet al.. Cytokine responses in severe acute respiratory" exact="syndrome" post="coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J"/>
  <result pre="response occurs via activation of the NF-kappaB pathway in human" exact="monocyte" post="macrophages in vitro. Virus Res. (2009) 142:19â€&quot;27. 10.1016/j.virusres.2009.01.00519185596 70.Al-QahtaniAALyroniKAznaourovaMTseliouMAl-AnaziMRAl-AhdalMNet"/>
  <result pre="vitro. Virus Res. (2009) 142:19â€&quot;27. 10.1016/j.virusres.2009.01.00519185596 70.Al-QahtaniAALyroniKAznaourovaMTseliouMAl-AnaziMRAl-AhdalMNet al.. Middle east" exact="respiratory" post="syndrome corona virus spike glycoprotein suppresses macrophage responses via"/>
  <result pre="Virus Res. (2009) 142:19â€&quot;27. 10.1016/j.virusres.2009.01.00519185596 70.Al-QahtaniAALyroniKAznaourovaMTseliouMAl-AnaziMRAl-AhdalMNet al.. Middle east respiratory" exact="syndrome" post="corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated"/>
  <result pre="TRIF contributes to a protective innate immune response to severe" exact="acute" post="respiratory syndrome coronavirus infection. MBio. (2015) 6:e00638â€&quot;15. 10.1128/mBio.00638-1526015500 72.GralinskiLEMenacheryVDMorganAPToturaALBeallAKocherJet"/>
  <result pre="contributes to a protective innate immune response to severe acute" exact="respiratory" post="syndrome coronavirus infection. MBio. (2015) 6:e00638â€&quot;15. 10.1128/mBio.00638-1526015500 72.GralinskiLEMenacheryVDMorganAPToturaALBeallAKocherJet al.."/>
  <result pre="to a protective innate immune response to severe acute respiratory" exact="syndrome" post="coronavirus infection. MBio. (2015) 6:e00638â€&quot;15. 10.1128/mBio.00638-1526015500 72.GralinskiLEMenacheryVDMorganAPToturaALBeallAKocherJet al.. Allelic"/>
  <result pre="7:1653â€&quot;63. 10.1534/g3.117.04143428592648 73.SheahanTMorrisonTEFunkhouserWUematsuSAkiraSBaricRSet al.MyD88 is required for protection from lethal" exact="infection" post="with a mouse-adapted SARS-CoV. PLoS Pathog. (2008) 4:e100024010.1371/journal.ppat.100024019079579 74.CookDNPisetskyDSSchwartzDA."/>
  <result pre="in different populations. Cell Discov. (2020) 6:11. 10.1038/s41421-020-0147-132133153 76.LimHKHuangSXLChenJKernerGGilliauxOBastardPet al.." exact="Severe" post="influenza pneumonitis in children with inherited TLR3 deficiency. J"/>
  <result pre="deficiency. J Exp Med. (2019) 216:2038â€&quot;56. 10.1084/jem.2018162131217193 77.ChannappanavarRFehrARVijayRMackMZhaoJMeyerholzDKet al.. Dysregulated" exact="type I" post="interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in"/>
  <result pre="Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal" exact="pneumonia" post="in SARS-CoV-infected mice. Cell Host Microbe. (2016) 19:181â€&quot;93. 10.1016/j.chom.2016.01.00726867177"/>
  <result pre="Cell Host Microbe. (2016) 19:181â€&quot;93. 10.1016/j.chom.2016.01.00726867177 78.LeeCTFeinAMLippmannMHoltzmanHKimbelPWeinbaumG. Elastolytic activity in" exact="pulmonary" post="lavage fluid from patients with adult respiratory-distress syndrome. N"/>
  <result pre="78.LeeCTFeinAMLippmannMHoltzmanHKimbelPWeinbaumG. Elastolytic activity in pulmonary lavage fluid from patients with" exact="adult" post="respiratory-distress syndrome. N Engl J Med. (1981) 304:192â€&quot;6. 10.1056/NEJM1981012230404026969364"/>
  <result pre="Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in" exact="acute" post="lung injury and ARDS. Chest. (2014) 146:1081â€&quot;91. 10.1378/chest.14-039725287998 80.SallenaveJMDonnellySCGrantISRobertsonCGauldieJHaslettC."/>
  <result pre="Secretory leukocyte proteinase inhibitor is preferentially increased in patients with" exact="acute" post="respiratory distress syndrome. Eur Respir J. (1999) 13:1029â€&quot;36. 10.1183/09031936.99.1351029910414400"/>
  <result pre="leukocyte proteinase inhibitor is preferentially increased in patients with acute" exact="respiratory" post="distress syndrome. Eur Respir J. (1999) 13:1029â€&quot;36. 10.1183/09031936.99.1351029910414400 81.KidoHOkumuraYTakahashiEPanHYWangSYaoDet"/>
  <result pre="Microbes Infect. (2018) 7:77. 10.1038/s41426-018-0063-829691378 85.Delgado-OrtegaMMarcDDupontJTrappSBerriMMeurensFet al.. SOCS proteins in" exact="infectious diseases" post="of mammals. Vet Immunol Immunopathol. (2013) 151:1â€&quot;19. 10.1016/j.vetimm.2012.11.00823219158 86.PothlichetJChignardMSi-TaharM."/>
  <result pre="signaling 4 (SOCS4) protects against severe cytokine storm and enhances" exact="viral" post="clearance during influenza infection. PLoS Pathog. (2014) 10:e1004134. 10.1371/journal.ppat.100413424809749"/>
  <result pre="without concomitant azithromycin among hospitalized patients testing positive for Coronavirus" exact="Disease" post="2019 (COVID-19). JAMA Cardiol. (2020). 10.1001/jamacardio.2020.1834. [Epub ahead of"/>
  <result pre="ahead of print].32376603 94.ArtsRJWMoorlagSNovakovicBLiYWangSYOostingMet al.. BCG vaccination protects against experimental" exact="viral infection" post="in humans through the induction of cytokines associated with"/>
  <result pre="of print].32376603 94.ArtsRJWMoorlagSNovakovicBLiYWangSYOostingMet al.. BCG vaccination protects against experimental viral" exact="infection" post="in humans through the induction of cytokines associated with"/>
  <result pre="175:1634â€&quot;50 e1617. 10.1016/j.cell.2018.09.04230433869 97.Iwata-YoshikawaNUdaASuzukiTTsunetsugu-YokotaYSatoYMorikawaSet al.Effects of toll-like receptor stimulation on" exact="eosinophilic" post="infiltration in lungs of BALB/c mice immunized with UV-inactivated"/>
  <result pre="infiltration in lungs of BALB/c mice immunized with UV-inactivated severe" exact="acute" post="respiratory syndrome-related coronavirus vaccine. J Virol. (2014) 88:8597â€&quot;614. 10.1128/JVI.00983-1424850731"/>
  <result pre="in lungs of BALB/c mice immunized with UV-inactivated severe acute" exact="respiratory" post="syndrome-related coronavirus vaccine. J Virol. (2014) 88:8597â€&quot;614. 10.1128/JVI.00983-1424850731 98.CoviÃ¡nCRetamal-DÃ­azABuenoSMKalergisAMCould"/>
  <result pre="pathways in the resolution or the exacerbation of coronavirus (CoV-2)" exact="infection" post="in COVID-19 disease: what therapeutic targets? (2020) 10.31219/osf.io/rtfmx Abbreviations"/>
  <result pre="disease: what therapeutic targets? (2020) 10.31219/osf.io/rtfmx Abbreviations CoV Coronavirus SARS" exact="Severe" post="Acute Respiratory Syndrome MERS Middle east respiratory syndrome ARDS"/>
  <result pre="what therapeutic targets? (2020) 10.31219/osf.io/rtfmx Abbreviations CoV Coronavirus SARS Severe" exact="Acute" post="Respiratory Syndrome MERS Middle east respiratory syndrome ARDS acute"/>
  <result pre="therapeutic targets? (2020) 10.31219/osf.io/rtfmx Abbreviations CoV Coronavirus SARS Severe Acute" exact="Respiratory" post="Syndrome MERS Middle east respiratory syndrome ARDS acute respiratory"/>
  <result pre="targets? (2020) 10.31219/osf.io/rtfmx Abbreviations CoV Coronavirus SARS Severe Acute Respiratory" exact="Syndrome" post="MERS Middle east respiratory syndrome ARDS acute respiratory disease"/>
  <result pre="CoV Coronavirus SARS Severe Acute Respiratory Syndrome MERS Middle east" exact="respiratory" post="syndrome ARDS acute respiratory disease syndrome HIV human immunodeficiency"/>
  <result pre="Coronavirus SARS Severe Acute Respiratory Syndrome MERS Middle east respiratory" exact="syndrome" post="ARDS acute respiratory disease syndrome HIV human immunodeficiency virus"/>
  <result pre="Severe Acute Respiratory Syndrome MERS Middle east respiratory syndrome ARDS" exact="acute" post="respiratory disease syndrome HIV human immunodeficiency virus S Spike"/>
  <result pre="Acute Respiratory Syndrome MERS Middle east respiratory syndrome ARDS acute" exact="respiratory" post="disease syndrome HIV human immunodeficiency virus S Spike E"/>
  <result pre="Respiratory Syndrome MERS Middle east respiratory syndrome ARDS acute respiratory" exact="disease" post="syndrome HIV human immunodeficiency virus S Spike E envelop"/>
  <result pre="Syndrome MERS Middle east respiratory syndrome ARDS acute respiratory disease" exact="syndrome" post="HIV human immunodeficiency virus S Spike E envelop M"/>
  <result pre="east respiratory syndrome ARDS acute respiratory disease syndrome HIV human" exact="immunodeficiency" post="virus S Spike E envelop M matrix N nucleocapsid"/>
  <result pre="hemagglutinin ACE2 angiotensin-converting enzyme 2 DPP4 Dipeptidyl peptidase 4 TTSP" exact="type II" post="transmembrane serine proteases TMPRSS Transmembrane protease serine NF-kB Nuclear"/>
  <result pre="serine NF-kB Nuclear Factor IL interleukin KO knock-out ATI alveolar" exact="type I" post="epithelial cell ATII alveolar type II epithelial cell PRR"/>
  <result pre="Nuclear Factor IL interleukin KO knock-out ATI alveolar type I" exact="epithelial" post="cell ATII alveolar type II epithelial cell PRR pattern"/>
  <result pre="KO knock-out ATI alveolar type I epithelial cell ATII alveolar" exact="type II" post="epithelial cell PRR pattern recognition receptors PAMPs pathogen-associated molecular"/>
  <result pre="ATI alveolar type I epithelial cell ATII alveolar type II" exact="epithelial" post="cell PRR pattern recognition receptors PAMPs pathogen-associated molecular patterns"/>
  <result pre="Toll-Like Receptors IFN interferon Mac macrophages DCs dendritic cells PBMC" exact="peripheral" post="blood mononuclear cells CCL2 C-C Motif Chemokine Ligand 2"/>
 </snippets>
</snippetsTree>
